Fanlu Li

579 total citations
13 papers, 261 citations indexed

About

Fanlu Li is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Fanlu Li has authored 13 papers receiving a total of 261 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Molecular Biology and 4 papers in Cancer Research. Recurrent topics in Fanlu Li's work include Pancreatic and Hepatic Oncology Research (6 papers), Cancer-related molecular mechanisms research (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Fanlu Li is often cited by papers focused on Pancreatic and Hepatic Oncology Research (6 papers), Cancer-related molecular mechanisms research (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Fanlu Li collaborates with scholars based in China, Australia and United Kingdom. Fanlu Li's co-authors include Baiyong Shen, Siyi Zou, Yizhi Cao, Chenlei Wen, Pengyi Liu, Minmin Shi, Xingfeng He, Zhiwei Xu, Yihao Liu and Qian Zhan and has published in prestigious journals such as Journal of Clinical Oncology, Frontiers in Immunology and Cancer Letters.

In The Last Decade

Fanlu Li

12 papers receiving 258 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fanlu Li China 8 173 123 55 47 26 13 261
Shuanglin Han Australia 6 180 1.0× 141 1.1× 66 1.2× 72 1.5× 23 0.9× 7 293
Xinrui Mao China 8 141 0.8× 141 1.1× 106 1.9× 71 1.5× 8 0.3× 13 301
Ian Lai United States 6 165 1.0× 73 0.6× 84 1.5× 85 1.8× 16 0.6× 9 260
Fangfang Bu China 8 173 1.0× 90 0.7× 107 1.9× 26 0.6× 53 2.0× 9 285
Huita Wu China 7 189 1.1× 93 0.8× 72 1.3× 22 0.5× 37 1.4× 15 273
Sara Malih Iran 10 224 1.3× 117 1.0× 33 0.6× 27 0.6× 26 1.0× 14 296
Zhenru Zhu China 6 202 1.2× 71 0.6× 135 2.5× 86 1.8× 19 0.7× 9 326
Manh Tien Tran Japan 10 299 1.7× 118 1.0× 56 1.0× 40 0.9× 10 0.4× 24 357
Lei Chang China 8 271 1.6× 216 1.8× 42 0.8× 47 1.0× 17 0.7× 12 373
Yanfeng Yin China 8 262 1.5× 197 1.6× 50 0.9× 73 1.6× 10 0.4× 8 361

Countries citing papers authored by Fanlu Li

Since Specialization
Citations

This map shows the geographic impact of Fanlu Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fanlu Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fanlu Li more than expected).

Fields of papers citing papers by Fanlu Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fanlu Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fanlu Li. The network helps show where Fanlu Li may publish in the future.

Co-authorship network of co-authors of Fanlu Li

This figure shows the co-authorship network connecting the top 25 collaborators of Fanlu Li. A scholar is included among the top collaborators of Fanlu Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fanlu Li. Fanlu Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
Zou, Siyi, Lei Zhang, Cen Jiang, et al.. (2024). Driver mutation subtypes involve with differentiated immunophenotypes influencing pancreatic cancer outcomes. Cancer Letters. 599. 217134–217134. 6 indexed citations
3.
Zhan, Qian, Chenlei Wen, Siyi Zou, et al.. (2024). Perioperative fuzuloparib plus mFOLFIRINOX for resectable pancreatic adenocarcinoma: A phase 1 study.. Journal of Clinical Oncology. 42(16_suppl). 4163–4163. 2 indexed citations
4.
5.
Ai, Qi, Fanlu Li, Siyi Zou, et al.. (2023). Targeting KRASG12V mutations with HLA class II-restricted TCR for the immunotherapy in solid tumors. Frontiers in Immunology. 14. 1161538–1161538. 8 indexed citations
6.
Wang, Xinjing, Xiayang Ying, Shuyu Zhai, et al.. (2023). Hypoxia-induced long non-coding RNA LINC00460 promotes p53 mediated proliferation and metastasis of pancreatic cancer by regulating the miR-4689/UBE2V1 axis and sequestering USP10. International Journal of Medical Sciences. 20(10). 1339–1357. 7 indexed citations
7.
Wang, Xuelong, Youwei Zhu, Yizhi Cao, et al.. (2022). The CTCF/LncRNA‐PACERR complex recruits E1A binding protein p300 to induce pro‐tumour macrophages in pancreatic ductal adenocarcinoma via directly regulating PTGS2 expression. Clinical and Translational Medicine. 12(2). e654–e654. 32 indexed citations
8.
Liu, Yihao, Minmin Shi, Xingfeng He, et al.. (2022). LncRNA-PACERR induces pro-tumour macrophages via interacting with miR-671-3p and m6A-reader IGF2BP2 in pancreatic ductal adenocarcinoma. Journal of Hematology & Oncology. 15(1). 52–52. 114 indexed citations
9.
Chen, Haoda, Fanlu Li, Siyi Zou, et al.. (2021). Preoperative plasma D-dimer independently predicts survival in patients with pancreatic ductal adenocarcinoma undergoing radical resection. World Journal of Surgical Oncology. 19(1). 166–166. 5 indexed citations
10.
Hao, Qian, Hongzhe Li, Junjie Xie, et al.. (2021). Immunity-Related Gene Signature Identifies Subtypes Benefitting From Adjuvant Chemotherapy or Potentially Responding to PD1/PD-L1 Blockage in Pancreatic Cancer. Frontiers in Cell and Developmental Biology. 9. 682261–682261. 5 indexed citations
11.
Zhang, Zehui, Siyi Zou, Fanlu Li, et al.. (2021). A Novel c-MET-Targeting Antibody-Drug Conjugate for Pancreatic Cancer. Frontiers in Oncology. 11. 634881–634881. 13 indexed citations
12.
Leng, Ling, Jie Ma, Baolin Guo, et al.. (2020). Comprehensive proteomic atlas of skin biomatrix scaffolds reveals a supportive microenvironment for epidermal development. Journal of Tissue Engineering. 11. 2752701718–2752701718. 21 indexed citations
13.
Mo, Ruidong, Peng Wang, Rongtao Lai, et al.. (2016). Persistently elevated circulating Th22 reversely correlates with prognosis in HBV‐related acute‐on‐chronic liver failure. Journal of Gastroenterology and Hepatology. 32(3). 677–686. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shuanglin Han Breakdown of academic impact, for papers by Xinrui Mao Breakdown of academic impact, for papers by Ian Lai Breakdown of academic impact, for papers by Fangfang Bu Breakdown of academic impact, for papers by Huita Wu Breakdown of academic impact, for papers by Sara Malih Breakdown of academic impact, for papers by Zhenru Zhu Breakdown of academic impact, for papers by Manh Tien Tran Breakdown of academic impact, for papers by Lei Chang Breakdown of academic impact, for papers by Yanfeng Yin
Rankless by CCL
2026